Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal

BACKGROUND: The objective of this study was to identify a subgroup of patients with head and neck squamous cell carcinoma (HNSCC) who might be suitable for hypofractionated radiotherapy (RT‐hypo) during the COVID‐19 pandemic. METHODS: HNSCC cases (oropharynx/larynx/hypopharynx) treated with definiti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer
Autores principales: Huang, Shao Hui, O’Sullivan, Brian, Su, Jie, Ringash, Jolie, Bratman, Scott V., Kim, John, Hosni, Ali, Bayley, Andrew, Cho, John, Giuliani, Meredith, Hope, Andrew, Spreafico, Anna, Hansen, Aaron R., Siu, Lillian L., Gilbert, Ralph, Irish, Jonathan C., Goldstein, David, de Almeida, John, Tong, Li, Xu, Wei, Waldron, John
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300809/
https://ncbi.nlm.nih.gov/pubmed/32478895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32968
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares